Please review the letter from Nova Scotia Health’s Physician Lead for Addiction Medicine, Dr. David Martell, which outlines recent changes to the administration of Long-Acting Injectable Buprenorphine (LAIB/Sublocade®) for all Nova Scotia Health OAT providers and ORP, RSC, and IWMU staff.
Access the letter here